ChemChina $43 billion acquisition of Syngenta

5/5/2017
Acquisition finance, Public acquisition

$ 43 billion

Completed

5/5/2017


Overview:

  • State-owned ChemChina has acquired Swiss agribusiness company Syngenta for $43 billion.
  • It was part-financed through $20 billion bridge facilities provided by HSBC Bank. This was structured as $15 billion in term bridge facilities along with $5 billion in backstop facilities, made available for the purposes of refinancing existing debt in Syngenta
  • The deal is set to become largest ever overseas acquisition by a Chinese company, more than double the previous largest acquisition - CNOOC's $17.7 billion purchase of Canada's Nexen in 2012.
  • The transaction is a setback for US seed company Monsanto, who unsuccessfully bid $45 billion for Syngenta last year.
  • In March, ChemChina bought Italian tyre maker Pirelli, underscoring the company’s interest in Europe.
  • In mid-May 2017, ChemChina completed its first settlement of the tender offers for Syngenta.

Adam Majeed - Asia Editor

Jurisdictions:

United States
China
Switzerland

Deal types:

Acquisition finance
Public acquisition

Practice area:

M&A

Governing law:

Switzerland

Industry sectors:

Pharmaceuticals and life sciences
Food and beverage
Agriculture


Firms:

Party: Syngenta (Target)


Party: China CITIC Bank Corporation Ltd (Lender)


Party: Syngenta (Target)


Party: Syngenta (Target)


Party: ChemChina (Acquirer)


Party: ChemChina (Acquirer)


Party: HSBC (Lender)

Lawyer: Ian Callaghan


Party: China CITIC Bank Corporation Ltd (Lender)

Lawyer: Daniel Hayek


Party: ChemChina (Acquirer)